Dr Lucy Harper

Chief Executive, Applied Microbiology International

After completing a BSc in Medical Biochemistry at Birmingham University, Lucy worked in hospital laboratories and university departments across the West Midlands. In 2003 she completed a PhD titled: Renal Dopamine and Salt-Sensitive Hypertension and continued her research career, completing several postdoc projects. During this time, she was offered the honorary editorship of Microbiologist magazine and when her postdoc contract ended, she took the position of Communications Officer for Med-Vet-Net, the EU FP6 project on zoonotic disease. Lucy began working for SfAM in June 2006 and in 2010 was awarded an MBA with distinction. Lucy was appointed as Chief Executive of AMI in November 2014.

Professor Brendan Gilmore

President of the Society for Applied Microbiology

Professor Brendan Gilmore holds the Chair of Pharmaceutical Microbiology at Queen’s University Belfast, where he leads the Biofilm Research Group. His research is focused on understanding the processes which govern bacterial biofilm formation and tolerance to antibiotics, and the discovery of novel antibiotics, anti-biofilm agents and disinfectant approaches. His recent work has included the application of cold plasmas for biofilm decontamination, discovery of novel antimicrobials and biocatalytic enzymes from extremely halophilic microorganisms and uncovering novel druggable protease targets in bacterial biofilm formation among the ESKAPE pathogens.

: https://pure.qub.ac.uk/en/persons/brendan-gilmore
: @BrendanFGilmore